Disrupted MEK/ERK signaling in the medial orbital cortex and dorsal endopiriform nuclei of the prefrontal cortex in a chronic restraint stress mouse model of depression

Neuroscience Letters

Volumn 580, Issue , 2014, Pages 163-168

  Leem, Yea Hyun ^a   Yoon, Sang Sun ^a   Kim, Yu Han ^a   Jo, Sangmee Ahn ^a  

^a Dankook University   (South Korea)

Author keywords

Dorsal endopiriform nuclei; ERK; Medial orbital cortex; MEK; Restraint stress; Social interaction

Indexed keywords

IMIPRAMINE; MITOGEN ACTIVATED PROTEIN KINASE; ANTIDEPRESSANT AGENT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR CHANGE; CHRONIC STRESS; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; ENZYME PHOSPHORYLATION; IMMOBILIZATION STRESS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOTOR CORTEX; MOUSE; NONHUMAN; ORBITAL CORTEX; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOCIAL INTERACTION; SOCIAL INTERACTION TEST; TAIL SUSPENSION TEST; WEIGHT GAIN; ANIMAL; C57BL MOUSE; CHRONIC DISEASE; DRUG THERAPY; ENZYMOLOGY; EXERCISE; MENTAL STRESS; METABOLISM; PHOSPHORYLATION; PSYCHOLOGY; PYRIFORM CORTEX;

ANIMALS; ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; DEPRESSION; IMIPRAMINE; MALE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PIRIFORM CORTEX; PREFRONTAL CORTEX; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL;

EID: 84906487289     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.08.001     Document Type: Article

References (23)

1. Ader R., Cohen N. Psychoneuroimmunology: conditioning and stress. Annu. Rev. Psychol. 1993, 44:53-85.
2. Berton O., Nestler E.J. New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 2006, 7:137-151.
3. Christiansen S.H., Olesen M.V., wortwein G., Woldbye D.P. Fluoxetine reverts chronic restraint stress-induced depression-like behavior and increases neuropeptide Y and galanin expression in mice. Behav. Brain Res. 2011, 216:585-591.
4. Duman C.H., Schlesinger L., Kodama M., Russell D.S., Duman R.S. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol. Psychiatry 2007, 61:661-670.
5. Dwivedi Y., Rizavi H.S., Conley R.R., Pandey G.N. ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol. Psychiatry 2006, 11:86-98.
6. Dwivedi Y., Rizavi H.S., Zhang H., Roberts R.C., Conley R.R., Pandey G.N. Aberrant extracellular signal-regulated kinase (ERK)1/2 signaling in suicide: role of ERK kinase 1 (MEK1). Int. J. Neuropsychopharmacol. 2009, 12:1337-1354.
7. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J. Neurosci. 2003, 23:7311-7316.
8. Golden S.A., Covington H.E., Berton O., Russo S.J. A standardized protocol for repeated social defeat stress in mice. Nat. Protoc. 2011, 6:1183-1191.
9. Gourly S.L., Wu F.J., Kiraly D.D., Ploski J.E., Kedves A.T., Duman R.S., Tayer J.R. Regionally specific regulation of ERK MAP kinase in model of antidepressant-sensitive chronic depression. Biol. Psychiatry 2008, 63:353-359.
10. Iniguez S.D., Alcantara L.F., Warren B.L., Riggs L.M., Parise E.M., Vialou V., Wright K.N., Dayrit G., Nieto S.J., Wilkinson M.B., Lobo M.K., Neve R.L., Nestler E.J., Bolanos-Guzman C.A. Fluoxentine exposure during adolescence alters response to aversive stimuli in adulthood. J. Neurosci. 2014, 34:1007-1021.
11. Iniguez S.D., Vialou V., Warren B.L., Cao J.L., Alcantara L.F., Davis L.C., Manojlovic Z., Neve R.L., Russo S.J., Han M.H., Nestler E.J., Bolanos-Guzman C.A. Extracellular signal-regulated kinase-2 within the ventral tegmental area regulates response to stress. J. Neurosci. 2010, 30:7652-7663.
12. Koenigs M., Grafman J. The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav. Brain Res. 2009, 201:239-243.
13. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., Laplant Q., Graham A., Lutter M., Lagace D.C., Ghose S., Reister R., Tannous P., Green T.A., Neve R.L., Chakravarty S., Kumar A., Eisch A.J., Self D.W., Lee F.S., Tamminga C.A., Cooper D.C., Gershenfeld H.K., Nestler E.J. Molecular adaptations underlying susceptible and resistance to social defeat in brain reward regions. Cell 2007, 131:391-404.
14. Lu J., Liang J., Wang J.R., Hu L., Tu Y., Guo J.Y. Acupuncture activates ERK-CREB pathway in rats exposed to chronic unpredictable mild stress. Evid. Based Complement. Altern. Med. 2013, 2013:469765-469771.
15. Mazzucchelli C., Brambilla R. Ras-related and MAPK signaling in neuronal plasticity and memory formation. Cell. Mol. Life Sci. 2000, 57:604-611.
16. Moy S.S., Nadler J.J., Perez A., Barbaro R.P., John J.M., Magnuson T.R., Piven J., Crawley J.N. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 2004, 3:287-302.
17. Nesler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 2006, 59:1151-1159.
18. Poo M.M. Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2001, 2:24-32.
19. Roberson E.D., English J.D., Adams J.P., Selcher J.C., Kondrratick C., Sweatt J.D. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. J. Neurosci. 1999, 19:4337-4348.
20. Shirayama Y., Chen A.C-H., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 2002, 22:3251-3261.
21. Sweatt J.D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 2001, 76:1-10.
22. van Praag H.M. Can stress cause depression?. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2004, 28:891-907.
23. Venzala E., Garcia-Garcia A.L., Elizalde N., Delagrange P., Tordera R.M. Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors. Psychopharmacology 2012, 224:313-325.